Inhibition of S6K1 enhances glucose deprivation-induced cell death via downregulation of anti-apoptotic proteins in MCF-7 breast cancer cells.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Biochemical and Biophysical Research Communications - BBRC

• Publication date

  2013-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.bbrc.2013.01.074PMID 23376066
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Phosphorylated S6K1 is a possible marker for endocrine therapy resistance in hormone receptor-positive breast cancer

  2011cited by this paper
• Sorafenib induces apoptotic cell death in human non-small cell lung cancer cells by down-regulating mammalian target of rapamycin (mTOR)-dependent survivin expression.

  2011cited by this paper
• Characterization of PF-4708671, a novel and highly specific inhibitor of p70 ribosomal S6 kinase (S6K1).

  2010cited by this paper
• S6 Kinase 1 Regulates Estrogen Receptor α in Control of Breast Cancer Cell Proliferation*

  2009cited by this paper
• Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation

  2009cited by this paper
• mTORC1 promotes survival through translational control of Mcl-1

  2008cited by this paper
• Cancer cell metabolism: Warburg and beyond.

  2008cited by this paper
• Effects of dietary energy restriction on gene regulation in mammary epithelial cells.

  2007cited by this paper
• A new mutational AKTivation in the PI3K pathway.

  2007cited by this paper
• Regulation of survivin expression by IGF-1/mTOR signaling

  2007cited by this paper
• Energy Deregulation: Licensing Tumors to Grow

  2006cited by this paper
• TOR signaling in growth and metabolism.

  2006cited by this paper
• Role of Raf kinase in cancer: therapeutic potential of targeting the Raf/MEK/ERK signal transduction pathway.

  2006cited by this paper
• How do cancer cells acquire the fuel needed to support cell growth?

  2005cited by this paper
• Apoptosis Induced by the Kinase Inhibitor BAY 43-9006 in Human Leukemia Cells Involves Down-regulation of Mcl-1 through Inhibition of Translation*

  2005cited by this paper
• Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression

  2004cited by this paper
• Kinase Inhibition with BAY 43–9006 in Renal Cell Carcinoma

  2004cited by this paper
• Overexpression of P70 S6 kinase protein is associated with increased risk of locoregional recurrence in node-negative premenopausal early breast cancer patients

  2004cited by this paper
• The 17q23 Amplicon and Breast Cancer

  2003cited by this paper
• The bioenergetic signature of cancer: a marker of tumor progression.

  2002cited by this paper
• Detecting activation of ribosomal protein S6 kinase by complementary DNA and tissue microarray analysis.

  2000cited by this paper
• On the origin of cancer cells.

  1956cited by this paper
• [Origin of cancer cells].

  1956cited by this paper

• Development of 6-amido-4-aminoisoindolyn-1,3-diones as p70S6K1 inhibitors and potential breast cancer therapeutics

  2024cites this paper
• S6K2 in Focus: Signaling Pathways, Post-Translational Modifications, and Computational Analysis

  2024cites this paper
• The crosstalk among the physical tumor microenvironment and the effects of glucose deprivation on tumors in the past decade

  2023cites this paper
• Diabetes mellitus and endometrial carcinoma: Risk factors and etiological links

  2022cites this paper
• Identification of a basement membrane-related gene signature for predicting prognosis and estimating the tumor immune microenvironment in breast cancer

  2022cites this paper
• Molecular Mechanisms of Anti-Estrogen Therapy Resistance and Novel Targeted Therapies

  2022cites this paper
• MiR-181a Promotes Spermatogenesis by Targeting the S6K1 Pathway

  2021cites this paper
• Distinct Roles of mTOR Targets S6K1 and S6K2 in Breast Cancer

  2020cites this paper
• Vitamin A deficiency impairs intestinal physical barrier function of fish

  2019cites this paper
• MicroRNA‐133b suppresses bladder cancer malignancy by targeting TAGLN2‐mediated cell cycle

  2018cites this paper
• Leukotriene B₄ Metabolism and p70S6 Kinase 1 Inhibitors: PF-4708671 but Not LY2584702 Inhibits CYP4F3A and the ω-Oxidation of Leukotriene B₄ In Vitro and In Cellulo

  2017cites this paper
• Quantitative structure activity relationship studies of anti-proliferative activity of some indole derivatives combining DFT calculations and statistical results

  2017cites this paper
• p53 modulates the effect of ribosomal protein S6 kinase1 (S6K1) on cisplatin toxicity in chronic myeloid leukemia cells

  2017cites this paper
• Association of ribosomal protein S6 kinase 1 with cellular radiosensitivity of non-small lung cancer

  2017cites this paper
• Alternative splicing of S6K1 promotes non-small cell lung cancer survival

  2016cites this paper
• TRAIL restores DCA/metformin-mediated cell death in hypoxia.

  2016cites this paper
• Pinin associates with prognosis of hepatocellular carcinoma through promoting cell proliferation and suppressing glucose deprivation-induced apoptosis

  2016cites this paper
• Targeting HIF-1α is a prerequisite for cell sensitivity to dichloroacetate (DCA) and metformin.

  2016cites this paper
• Glucose promotes cell proliferation, glucose uptake and invasion in endometrial cancer cells via AMPK/mTOR/S6 and MAPK signaling.

  2015cites this paper
• Broad targeting of resistance to apoptosis in cancer

  2015cites this paper
• Effect of survivin siRNA on biological behaviour of breast cancer MCF7 cells.

  2015cites this paper
• The role of mitochondria in mTOR‐regulated longevity

  2015influential citation
• S6 inhibition contributes to isoflurane neurotoxicity in the developing brain.

  2015cites this paper
• Nutrient depletion and metabolic profiles in breast carcinoma cell lines measured with a label-free platform

  2015cites this paper
• Inhibition of S6K1 enhances dichloroacetate-induced cell death

  2015cites this paper
• PF-4708671, a specific inhibitor of p70 ribosomal S6 kinase 1, activates Nrf2 by promoting p62-dependent autophagic degradation of Keap1.

  2015cites this paper
• Metformin sensitizes human bladder cancer cells to TRAIL-induced apoptosis through mTOR/S6K1-mediated downregulation of c-FLIP

  2014cites this paper
• Blockage of Stat3 enhances the sensitivity of NSCLC cells to PI3K/mTOR inhibition.

  2014cites this paper
• Piperlongumine induces cell death through ROS-mediated CHOP activation and potentiates TRAIL-induced cell death in breast cancer cells

  2014cites this paper
• Evodiamine Induces Apoptosis and Enhances TRAIL-Induced Apoptosis in Human Bladder Cancer Cells through mTOR/S6K1-Mediated Downregulation of Mcl-1

  2014cites this paper
• Iron chelators induce autophagic cell death in multiple myeloma cells.

  2014cites this paper
• Coordinate activation of Shh and PI3K signaling in PTEN-deficient glioblastoma: new therapeutic opportunities

  2013cites this paper
• PIH1D1 interacts with mTOR complex 1 and enhances ribosome RNA transcription

  2013cites this paper
• Inhibition of vacuolar H+ ATPase enhances sensitivity to tamoxifen via up-regulation of CHOP in breast cancer cells.

  2013cites this paper
• Targeted Therapy for Breast Cancer Prevention

  2013cites this paper
• S6K1 inhibition enhances tamoxifen-induced cell death in MCF-7 cells through translational inhibition of Mcl-1 and survivin

  2013cites this paper